Skip to content
IV Injection Allopathic

NovoSeven 1 mg/vial iv injection

Generic: Coagulation Factor VIIa [Eptacog Alfa]

Company: Novo Nordisk Pharma (Pvt.) Ltd. Prices are as listed on BestinMeds; your pharmacy price may differ.

Strength1 mg/vial
PackNot listed yet

Reviewed by: not listed yet. Source: not listed yet.

Last updated July 28, 2025.

Compare

Same generic, same strength

Sorted by price per iv injection. Ask your pharmacist before you switch brands.

Coagulation Factor VIIa [Eptacog Alfa] 1 mg/vial iv injections

Prices as listed on BestinMeds.

No price is listed for this strength yet.

Advertisement

Google Ads 970 x 250
Google Ads 300 x 250
Medicine guide

About this medicine

What this medicine is for, how to take it, and what to watch for.

Read the full Coagulation Factor VIIa [Eptacog Alfa] guide

Indications

Hemophilia Coagulation Factor VIIa is indicated in Bleeding episodes in patients with haemophilia, Bleeding episodes due to surgery or invasive procedures in patients with factor VII deficiency, Bleeding episodes due to surgery or invasive procedures in Glanzmann's thrombasthenia

Dosage and administration

Bleeding episodes in patients with haemophilia: Adult: As activated eptacog alfa: Initially, 90 mcg/kg given via IV bolus over 2-5 min. Additional dose may be given as needed to achieve or maintain haemostasis, initially 2-3 hrly. May adjust dose or dosing interval according to response. May continue therapy for up to 3 wk or more in cases of serious bleeding episodes. Bleeding episodes due to surgery or invasive procedures in patients with factor VII deficiency: Adult: As activated eptacog alfa: 15-30 mcg/kg 4-6 hrly via IV bolus over 2-5 min until haemostasis is achieved. Bleeding episodes due to surgery or invasive procedures in Glanzmann's thrombasthenia: Adult: As activated eptacog alfa: 90 mcg/kg 2 hrly via IV bolus over 2-5 min, give at least 3 doses.

Side effects

Nausea, vomiting, skin reactions, fever, headache and changes in BP. Rarely, anaphylaxis.

Precautions and warnings

Advanced atherosclerotic disease, crush injury, septicemia or disseminated intravascular coagulation. Patients w/ history of CHD, liver disease, undergoing major surgery, at risk of thromboembolic phenomena or disseminated intravascular coagulation. Remote possibility of hypersensitivity to mouse IgG, bovine IgG & other residual culture proteins. Monitor prothrombin time & factor VII coagulant activity in factor VII deficient patients. Pregnancy & lactation. Neonates.

Pregnancy and lactation

It is preferable to avoid use during pregnancy. Either studies in animals have revealed adverse effects on the foetus (teratogenic or embryocidal or other) and there are no controlled studies in women or studies in women and animals are not available. Drugs should be given only if the potential benefit justifies the potential risk to the foetus. It is unknown whether eptacog alfa is excreted in human breast milk. The excretion of eptacog alfa in milk has not been studied in animals.

Clinical details

BestinMeds shares medicine information to help you compare. It does not replace advice from your doctor or pharmacist.

Advertisement

Google Ads 970 x 250
Google Ads 300 x 250

Advertisement

Google Ads 970 x 250
Google Ads 300 x 250